Aromatic Heterocycle-Based DPP-IV Inhibitors: Xanthines and Related Structural Types.

Authors: Szczepankiewicz, Bruce G.; Kurukulasuriya, Ravi

Source: Current Topics in Medicinal Chemistry, Volume 7, Number 6, March 2007 , pp. 569-578(10)

Publisher: Bentham Science Publishers

Buy & download fulltext article:

Price: $63.10 plus tax (Refund Policy)

Abstract:

Xanthines and xanthine-like DPP-IV inhibitors were first disclosed in 2002. Since then, several dozen accounts of xanthine-based DPP-IV inhibitors have been published. Only a few presentations and journal articles have appeared, with the vast majority of information coming from the patent literature. DPP-IV inhibitors related to the xanthines include purine analogues with other arrangements of the nitrogen atoms in the core structure, imidazoles, uracils, pyrimidines, pyridines, and some fused pyridines. At least one compound derived from the xanthines has advanced into clinical trials, making it likely that these molecules will play a major role in the DPP-IV inhibition arena over the next several years.

Keywords: xanthine mimetics; PYRIMIDINE-BASED DPP-IV INHIBITORS; URACIL-BASED DPP-IV INHIBITORS; Imidazole; ADME

Document Type: Research article

Publication date: 2007-03-01